Search
Patexia Community
News and Analysis

Our Members

All »
Bharat Ram Ambati
Seth Levy
Mehdi y
Koel Mukherjee
shimaa osama
Navid Zanganeh
Brian Smirke
Jessie S
Karen Fernley
Thomas James
keith white
omid sharifi
shash sen
j g shah shah
Kourosh Salehi

Innovation, Technology, and IP News

Major Med Device Product Developer GE HealthCare Collaborating with Healthcare Providers

Written by: Kregg Koch For good reasons, including product safety, quality assurance, development of delivery procedures and instructions, it has been a common practice for medical...

Fresh From the Bench: Latest Precedential Patent Cases

CASE OF THE WEEK Baxalta Inc. v. Genentech, Inc., Appeal No. 22-1461 (Fed. Cir. Sept. 20, 2023) Our Case of the Week focuses on the enablement requirement. It’s the first case...

Enter TitleFederal Circuit Revisits Standard for Enablement of Antibody Claims

Written by: Ashley C. Morales & Joseph Mallon, Ph.D. In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit affirmed the district court’s decision...

Fresh From the Bench: Latest Precedential Patent Cases

CASE OF THE WEEK Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., Appeal Nos. 2021-2299, -2338 (Fed. Cir. Sept. 15, 2023) In a decade-old case that has ...

Prosecution History May Support a Motivation to Combine

Written by: Rhett D. Ramsey & Jacob R. Rosenbaum Elekta Limited v. Zap Surgical Systems, Inc. Before: Reyna, Stoll, and Stark. Appeal from the Patent Trial and Appeal Board. ...

Landmark CAFC Cases in Patent Law: Shaping the Future of Innovation

In the ever-evolving landscape of patent law, the Court of Appeals for the Federal Circuit (CAFC) has played a pivotal role in shaping the rules and precedents governing intellectual...

Feed tagged as "pharmaceuticals":
Patexia Insight 185: From Flux to Surge: Is ANDA Litigation Rising?
Pedram Sameni Aug 30, 2023
We are proud to announce that tomorrow marks the release of the fourth edition of our ANDA Litigation Intelligence Report. This year's report... Read More »
Comment: 0 Favorite (0)
ANDA Litigation Resolutions: A Closer Look at Settlements and Their Consequences
Mikele Bicolli Aug 23, 2023
In the intricate world of pharmaceuticals, where innovation meets regulation, ANDA litigation stands as a pivotal battleground... Read More »
Comment: 0 Favorite (0)
Generic vs. Brand Drug Approval: Unveiling Differences and Similarities under the Hatch-Waxman Act
Mikele Bicolli Aug 16, 2023
In the realm of pharmaceuticals, the approval process for generic and brand-name drugs holds significant importance. The Hatch-Waxman Act, ... Read More »
Comment: 0 Favorite (0)
Navigating ANDA Litigation: Choosing the Best Attorneys and Law Firms
Mikele Bicolli Aug 9, 2023
Abbreviated New Drug Application (ANDA) litigation stands at the crossroads of pharmaceutical innovation and legal prowess. As generic... Read More »
Comment: 0 Favorite (0)
180-Day Exclusivity in Generic Drug Market: Understanding its Impact on Healthcare
Mikele Bicolli Aug 2, 2023
In the world of pharmaceuticals, access to affordable generic drugs is crucial for ensuring cost-effective healthcare solutions. The Drug... Read More »
Comment: 0 Favorite (0)
Patexia Insight 182: Downward Trends in Patent Litigation for the First Half of 2023
Pedram Sameni Jul 12, 2023
The landscape of patent litigation is ever-evolving, and the first half of 2023 has been no exception. The dynamics of patent litigation are... Read More »
Comment: 0 Favorite (0)
Analogous Art Must Be Compared to the Challenged Patent
Knobbe Martens Jun 9, 2023
Written by: Rhett D. Ramsey & Michael L. Fuller In Sanofi-Aventis Deutschland GmbH v. Mylan Pharm. Inc., Case No. 2021-1981, the... Read More »
Comment: 0 Favorite (0)
Merck Sues Federal Government Over Medicare Drug Price Negotiation Program
Knobbe Martens Jun 7, 2023
Written by: Brianne M. Kingery & Eric Furman, Ph.D. On June 6, 2023, Merck & Co. filed a lawsuit against the U.S. government... Read More »
Comment: 0 Favorite (0)
The Oncomouse Patent: A Milestone in Biotechnology Patents
Mikele Bicolli May 17, 2023
The Oncomouse patent stands as a remarkable milestone in the field of biotechnology patents, revolutionizing the way we approach... Read More »
Comment: 0 Favorite (0)
Implications of the Proposed EU Pharmaceutical Law Reform Overhaul
Knobbe Martens May 10, 2023
Written by:Nima Zargari, Ph.D.  & Joseph Mallon, Ph.D. On April 26, 2023, the European Commission proposed a pharmaceutical law... Read More »
Comment: 0 Favorite (0)
Ensuring a Reference Is Analogous Art to a Challenged Patent, Not to Another Reference
Knobbe Martens May 10, 2023
SANOFI-AVENTIS DEUTSCHLAND GMBH V. MYLAN PHARMACEUTICALS INC. Before Reyna, Mayer, and Cunningham. Appeal from Patent Trial and Appeal... Read More »
Comment: 0 Favorite (0)
Stipulated Dismissal Undercuts Bid for Attorneys’ Fees
Knobbe Martens May 9, 2023
Written by: Jeremy Anapol UNITED CANNABIS CORPORATION V. PURE HEMP COLLECTIVE INC. Before Lourie, Cunningham, and Stark... Read More »
Comment: 0 Favorite (0)
Claimed Ranges Overlapping the Prior Art Can Lead To Short Patent Shelf-Life
Knobbe Martens May 2, 2023
Written by: Matthew S. Whitehead & Douglas B. Wentzel UCB, INC.  v. ACTAVIS LABORATORIES UT, INC. Before Moore, Chen, and... Read More »
Comment: 0 Favorite (0)
Teva v. GSK: The “Skinny” Label Case Pending Before the Supreme Court
Knobbe Martens Apr 10, 2023
Written by: Ari Feinstein & Agnes Juang, Ph.D. On March 29, 2023, the Solicitor General of the United States asked the Supreme... Read More »
Comment: 0 Favorite (0)
Description Prescription
Knobbe Martens Mar 6, 2023
Written by: Brandon D. Hupka & Hans L. Mayer REGENTS OF THE UNIVERSITY OF MINNESOTA V. GILEAD SCIENCES, INC. Before... Read More »
Comment: 0 Favorite (0)
Patent Directed to System for Controlling Access to Drugs Is Not Listable in the Orange Book
Knobbe Martens Feb 27, 2023
Written by: Tyler S. Cox & Kendall Loebbaka JAZZ PHARMACEUTICALS, INC. v. AVADEL CNS PHARMACEUTICALS, LLC Before Lourie... Read More »
Comment: 0 Favorite (0)
BioNTech to Ship Modular mRNA Vaccine Factory to Rwanda
Knobbe Martens Jan 23, 2023
Written by: Mark Rubinshtein, Ph.D. Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in... Read More »
Comment: 0 Favorite (0)
Evidence of Actual Physician Practice is Relevant in Determination of Direct Infringement
Knobbe Martens Dec 27, 2022
Written by: Kendall Loebbaka & Cesar A. Estrada GENENTECH, INC. V. SANDOZ INC. Before Newman, Lourie, and Prost. Appeal... Read More »
Comment: 0 Favorite (0)
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
Pedram Sameni Nov 3, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More »
Comment: 0 Favorite (0)
Patexia Insight 155: Top ANDA Attorneys of 2022
Pedram Sameni Oct 20, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in ... Read More »
Comment: 0 Favorite (0)
Show more Newsfeed posts
Menu